Cytokine Levels and Human Herpesviruses in Saliva from Clinical Periodontal Healthy Subjects with Peri-Implantitis: A Case-Control Study

Carregando...
Imagem de Miniatura
Citações na Scopus
18
Tipo de produção
article
Data de publicação
2018
Título da Revista
ISSN da Revista
Título do Volume
Editora
HINDAWI LTD
Autores
MARQUES FILHO, Jaime S.
JR, Jorge Gobara
SALOMAO, Gustavo Vargas da Silva
SHIBLI, Jamil A.
VIANA, Renato G.
SCHWARTZ FILHO, Humberto O.
PALLOS, Debora
Citação
MEDIATORS OF INFLAMMATION, article ID 6020625, 7p, 2018
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
This study evaluated the presence of cytokines (IL-1 beta, IL-2, IL-4, IL-6, MCP-1, MIP-1 alpha , MIP-1 beta, and TNF-alpha) and human herpesvirus (HSVI, HSV2, EBV, CMV, VZV, HHV6, HHV7, and HHV8) in saliva samples taken from subjects with and without peri-implantitis. Forty-two periodontally healthy subjects were divided according to peri-implant condition: healthy and peri-implantitis groups. The clinical parameters as probing depth, clinical attachment level, plaque index, gingival bleeding, bleeding on probing, and suppuration were evaluated. For cytokine detection, multiplex analysis was performed, and PCR assay was used to identify herpesviruses. No significant differences were found in cytokine levels between groups (p > 0.05). The presence of herpesvirus was 1.97-fold higher in patients with peri-implantitis (odds ratio, CI 0.52-7.49). The association of the presence or absence of herpesvirus with the salivary markers was statistically significant for MIP-1 beta (p = 0.0087) and TNF-alpha (p = 0.0437) only in the peri-implantitis group. The presence of herpesviruses in patients with peri-implantitis suggests the development of a proinflammatory environment, which is characterized by increased expression of MIP-1 beta and TNF-alpha in saliva.
Palavras-chave
Referências
  1. Araujo MWB, 2003, J PERIODONTOL, V74, P1736, DOI 10.1902/jop.2003.74.12.1736
  2. Berglundh T, 2002, J CLIN PERIODONTOL, V29, P197, DOI 10.1034/j.1600-051X.29.s3.12.x
  3. Braz-Silva PH, 2017, J ORAL MICROBIOL, V9, DOI 10.1080/20002297.2017.1384287
  4. Contreras A, 2014, PERIODONTOL 2000, V64, P40, DOI 10.1111/j.1600-0757.2012.00448.x
  5. Darabi E, 2013, IRAN J ALLERGY ASTHM, V12, P75, DOI 012.01/ijaai.7580
  6. de Lima CL, 2016, J CLIN PERIODONTOL, V43, P492, DOI 10.1111/jcpe.12538
  7. Sarmento DJD, 2018, CLIN ORAL INVEST, V22, P885, DOI 10.1007/s00784-017-2166-3
  8. Edelman DC, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-78
  9. Faot F, 2015, J PERIODONTOL, V86, P631, DOI 10.1902/jop.2015.140603
  10. Gursoy UK, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00196
  11. Ito T, 2014, CLIN ORAL IMPLAN RES, V25, P977, DOI 10.1111/clr.12198
  12. Jankovic S, 2011, AUST DENT J, V56, P382, DOI 10.1111/j.1834-7819.2011.01360.x
  13. Jankovic S, 2011, INT J ORAL MAX SURG, V40, P271, DOI 10.1016/j.ijom.2010.11.004
  14. Johnson G, 2000, J CLIN MICROBIOL, V38, P3274
  15. Kaczor-Urbanowicz KE, 2017, EXP BIOL MED, V242, P459, DOI 10.1177/1535370216681550
  16. Mombelli A, 1999, PROCEEDINGS OF THE 3RD EUROPEAN WORKSHOP ON PERIODONTOLOGY: IMPLANT DENTISTRY, P281
  17. Nowzari H, 2008, CLIN IMPLANT DENT R, V10, P166, DOI 10.1111/j.1708-8208.2007.00076.x
  18. Nowzari H, 2008, CLIN IMPLANT DENT R, V10, P157, DOI 10.1111/j.1708-8208.2007.00075.x
  19. O'Brien-Simpson NM, 2017, J DENT RES, V96, P618, DOI 10.1177/0022034517691720
  20. Palmieri M, 2018, J ORAL MICROBIOL, V10, DOI 10.1080/20002297.2018.1476643
  21. Palmieri M, 2017, CLIN ORAL INVEST, V21, P2291, DOI 10.1007/s00784-016-2022-x
  22. Passoni BB, 2014, J APPL ORAL SCI, V22, P403, DOI 10.1590/1678-775720140055
  23. Perozini C, 2010, QUINTESSENCE INT, V41, P877
  24. Fonseca FJPO, 2014, CLIN ORAL IMPLAN RES, V25, pE68, DOI 10.1111/clr.12052
  25. PONTORIERO R, 1994, CLIN ORAL IMPLAN RES, V5, P254, DOI 10.1034/j.1600-0501.1994.050409.x
  26. Raab-Traub N, 2012, CURR OPIN VIROL, V2, P453, DOI 10.1016/j.coviro.2012.07.001
  27. Recker EN, 2015, J PERIODONTOL, V86, P264, DOI 10.1902/jop.2014.140354
  28. Saygun I, 2005, J PERIODONTAL RES, V40, P187, DOI 10.1111/j.1600-0765.2005.00790.x
  29. Shibli Jamil, 2015, J Int Acad Periodontol, V17, P71
  30. Shibli JA, 2008, CLIN ORAL IMPLAN RES, V19, P975, DOI 10.1111/j.1600-0501.2008.01566.x
  31. Slots J, 2015, PERIODONTOL 2000, V69, P28, DOI 10.1111/prd.12085
  32. Slots J, 2011, PERIODONTOL 2000, V55, P48, DOI 10.1111/j.1600-0757.2010.00361.x
  33. Verdugo F, 2015, CLIN ORAL INVEST, V19, P535, DOI 10.1007/s00784-014-1250-1
  34. Verdugo F, 2015, CLIN IMPLANT DENT R, V17, P199, DOI 10.1111/cid.12083